BRIEF-Pphc Expands Texas Footprint With Strategic Acquisition Of Pine Cove Capital-January 2024-www.financetom.com

BRIEF-Pphc Expands Texas Footprint With Strategic Acquisition Of Pine Cove Capital

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Pphc Expands Texas Footprint With Strategic Acquisition Of Pine Cove Capital

Jul 14, 2025 4:46 AM

Public Policy Holding Company Inc:

* PPHC EXPANDS TEXAS FOOTPRINT WITH STRATEGIC ACQUISITION OF

PINE

COVE CAPITAL

* PUBLIC POLICY HOLDING COMPANY INC - GEORGE P. BUSH

APPOINTED CEO

OF NEW PPHC PRACTICE

* PUBLIC POLICY HOLDING COMPANY INC - DEAL EXPECTED TO CLOSE

AUGUST 2025, ACCRETIVE TO EARNINGS

* PUBLIC POLICY HOLDING COMPANY INC - DEAL INCLUDES EARNOUT

PAYMENTS CAPPED AT $13 MILLION

Source text:

Further company coverage:

Previous page： --Netflix Reports Q2 Earnings of $4.88 a Share vs. Street Estimate of $4.74 Next page： --Netflix Posts Q2 EPS of $4.88 on Revenue of $9.6 Billion, vs CIQ Analyst Consensus of $4.76/Share on Revenue of $9.5 Billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Netflix Reports Q2 Earnings of $4.88 a Share vs. Street Estimate of $4.74

Jul 18, 2024

04:02 PM EDT, 07/18/2024 (MT Newswires) -- Price: 619.94, Change: -23.10, Percent Change: -3.59 ...

--Netflix Posts Q2 EPS of $4.88 on Revenue of $9.6 Billion, vs CIQ Analyst Consensus of $4.76/Share on Revenue of $9.5 Billion

Jul 18, 2024

04:00 PM EDT, 07/18/2024 (MT Newswires) -- Price: 642.95, Change: -4.51, Percent Change: -0.70 ...

Dr. Reddy's Laboratories to Market Takeda's Acid-Reflux Medication in India

Jul 18, 2024

04:01 PM EDT, 07/18/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) on Thursday disclosed plans to commercialize and sell Takeda Pharmaceutical's ( TAK ) vonoprazan tablets to treat gastroesophageal reflux disease, peptic and duodenal ulcers and similar disorders to customers in India. Under the terms of the non-exclusive patent licensing agreement, Dr. Reddy's plans to market the orally active potassium...

Benson Hill Plans 1-for-35 Reverse Stock Split to Regain NYSE Compliance

Jul 18, 2024

04:02 PM EDT, 07/18/2024 (MT Newswires) -- Benson Hill ( BHIL ) is planning a 1-for-35 reverse split of its common stock to take effect after Thursday's market close after the proposal was approved earlier in the day by shareholders at its annual meeting. The crop genetics company said the reverse split is intended to help it regain compliance with...